Vested shares, ISOs, RSUs, tender offers; more of your net worth sits in one company every year. The same company that signs your paycheck. Amplius helps SpaceX shareholders turn concentrated equity into a diversified, tax-smart plan, on your timeline and on your terms.
You didn't set out to put most of your wealth in one stock. It accumulated, RSUs settle, ISO spreads widen as the 409A climbs. Tender offers come and go, and the position keeps growing. One day you run the numbers and 70–90% of your net worth is SpaceX, alongside your salary, your benefits, and your career.
That isn't conviction. That's exposure.
Holding longer can feel like the smart move. The story is strong, the trajectory has been remarkable, and selling feels like leaving money on the table. But a diversified plan isn't a bet against SpaceX; it's a decision to preserve the wealth you've already earned.
The math is unforgiving: a 50% decline requires a 100% gain just to break even. If 80% of your net worth is one stock and it falls 40%, your total net worth drops 32%. Research from J.P. Morgan Asset Management has found that a significant share of individual stocks (on the order of 40%) suffer catastrophic declines they never fully recover from, and the figure runs higher for technology companies. Private markets can mask volatility; public markets don't.
Three ways concentration gradually raises the stakes:
Gains and losses aren't symmetrical. Down 50% needs up 100%. A diversified portfolio doesn't just grow; it survives the cycles that let compounding work.
Your paycheck, benefits, equity, and career all trace back to one company. A single change at SpaceX can touch all of them at once.
Pre-IPO shares aren't cash. You can't sell on a bad day. Tender windows are periodic and can be cut back. Your net worth on paper may not be your net worth when you need it.
Most SpaceX shareholders sense they're concentrated, but few have put a number on it. Taking about a minute each, these tools are educational estimates, a starting point for a real conversation, not a recommendation.
Measure your total SpaceX exposure across wealth, income, and liquidity.
For educational purposes only. Not investment or tax advice.
Model how diversified proceeds could generate income that doesn't depend on your time.
For educational purposes only. Not investment or tax advice.
Sustainable annual income your diversified base could produce:
Withdrawal-rate ranges draw on long-standing safe-withdrawal research. They are illustrations, not guarantees; actual results depend on allocation, fees, market conditions, and your full financial picture.
Diversifying a concentrated position is rarely one move. It's a coordinated set of them, sequenced across tax years to keep more of what you've built. These are the strategies in the Amplius Concentrated Stock Playbook. The right mix depends entirely on your basis, your timeline, and your goals.
A collar wraps your stock in a protective band: buy a put to set a floor, sell a call to help pay for it. Often structured at low or zero net cost. You keep ownership while capping the worst case. The trade-off: Your upside is capped too.
A long/short portfolio tracks the market while systematically harvesting losses. Those losses can offset the gains from selling concentrated stock. No multi-year lockup, you own the securities directly, and first-year harvested losses can be a noteworthy share of invested capital.
EFR uses options to cut single-stock risk substantially and replace it with broad-market exposure—without a taxable event today. Daily liquidity, standard 1099 reporting, no qualified-purchaser requirement, and no seven-year lockup.
Contribute your shares into a pooled partnership and receive a diversified basket in return (no tax at contribution). The classic tool, but harder to use now: strict eligibility, a seven-year lockup, and higher fees.
Reinvest capital gains into opportunity zone real estate for a "triple" benefit: defer the original gain, step-up basis over time, and (if held 10+ years) pay no tax on the QOZ investment's own growth. Made permanent under recent legislation.
Sell a call above today's price and collect cash now. You're effectively paid to set a limit order at a price you'd be glad to sell at. The trade-off: Upside above the strike goes to the buyer.
If you're already charitably inclined, donating appreciated stock can beat donating cash. A donor-advised fund lets you "bunch" deductions in a high-income year; a charitable remainder trust can diversify inside the trust and pay you an income stream. Capital gains on donated shares may be avoided entirely.
Hypothetical: $10M in SpaceX stock, $100K cost basis, 23.8% federal rate on long-term gains.
Estimated tax bill from selling $6M of stock outright.
Retain $3.75M (hold, collar, and EFR) and address $6.25M through a coordinated mix: long/short tax-loss harvesting, a qualified opportunity zone, an exchange fund, and a donor-advised fund.
About a 56% reduction. The collar and EFR reduce SpaceX risk further with no current tax.
Hypothetical illustration. Figures are estimates for educational purposes only and will vary with your facts. Not investment or tax advice.
The strategies above, in one place, with side-by-side comparisons, illustrative numbers, and a clear next-step road map. Written specifically for SpaceX shareholders weighing how and when to diversify.
ISOs and RSUs both build wealth, and each carries its own decisions, deadlines, and tax treatment. Getting them right is where a lot of value is won or lost.
ISOs give you the right to buy shares at a fixed strike price. The leverage is real, and so is the complexity. Exercising and holding can trigger the alternative minimum tax (AMT) on the "spread" between your strike and the current 409A value—even though you haven't sold a thing. Exercise early enough and you start the clock toward long-term capital gains treatment. Wait too long, and a rising 409A can make exercising prohibitively expensive; and a departure usually starts a tight 90-day window to act.
The art is exercising enough each year to make progress without an outsized AMT surprise. That's what the calculator below estimates.
RSUs are more straightforward, with one catch to plan around. They're taxed as ordinary income on their full value when they settle. For a pre-IPO company, that's often "double-trigger"; settlement waits for a liquidity event. When it lands, it can be large, and standard payroll withholding (frequently 22%) routinely falls short of what a high earner actually owes. The gap becomes an April surprise. A "sell-on-vest" default and a withholding check keep that from happening.
Estimate the cash to exercise and the potential AMT impact of exercising and holding.
A rough, educational estimate using 2025 federal figures and a simplified AMT calculation. It ignores state tax, other AMT adjustments, and credits. Your actual result depends on your full return, so confirm with your CPA before exercising.
Estimate the tax due when RSUs settle—and the gap typical withholding can leave.
A rough, educational estimate using 2025 federal figures. Actual tax depends on your full return, your state, and your employer's withholding, so confirm with your CPA.
Concentrated-stock planning works best when tax strategy, risk management, and investment design are coordinated, then implemented with discipline. Here's how that runs at Amplius.
We quantify the real number, vested and unvested equity, ISOs, RSUs, and how it all sits against the rest of your financial life. Most people are more concentrated than they think.
We define the point where your diversified portfolio can sustain your life without depending on any single stock. That target turns "Should I sell?" into "Here's the plan."
We sequence sales, exercises, hedges, and gifts across multiple tax years (using the playbook strategies that fit your basis and timeline) to keep more of what you've built.
Proceeds move into a diversified portfolio designed to grow, weather cycles, and eventually produce income. Concentrated equity becomes a durable, independent asset base.
As an independent fiduciary firm, Amplius is paid to advise, not sell you a product. Every recommendation answers one question: Is this right for you?
A short, no-pressure conversation is the fastest way to find out. We'll look at your actual position, talk through the tax-aware paths open to you, and outline what to consider now versus later. No obligation, no jargon.
For educational purposes only. Not investment, tax, or legal advice. Amplius Wealth Advisors, LLC (“Amplius Wealth”) is a Registered Investment Advisor (“RIA”) with the U.S. Securities and Exchange Commission (“SEC”). Amplius Wealth provides investment advisory and related services to clients. Amplius Wealth will notice file and/or register in such jurisdictions as required by the SEC or various state regulators. Amplius Wealth renders individualized responses only after complying with regulatory requirements or pursuant to an applicable state exemption or exclusion. Nothing provided herein constitutes tax advice. Individuals should seek the advice of their own tax advisor for specific information regarding tax consequences of investments. Investments in securities entail risk and are not suitable for all investors. This is not a recommendation nor an offer to sell (or solicitation of an offer to buy) securities in the United States or in any other jurisdiction. This website is intended to provide general information about Amplius Wealth and its team. It is not intended to offer investment advice or to recommend the purchase or sale of any investment product. Information is provided to learn about our advisory services and our people as well as to contact us for further information. Market data, articles and other content on this web site are based on generally available information and are believed to be reliable. Amplius Wealth does not guarantee the accuracy of the information contained on this website. The information is of a general nature and should not be construed as investment advice. Amplius Wealth will provide all prospective clients with a copy of our current Form ADV Part 2A (“Disclosure Brochure”), Form CRS (“Client Relationship Summary”) and the Brochure Supplement for each advisory person supporting a particular client. You may obtain a copy of these disclosures on the SEC website at http://adviserinfo.sec.gov or you may contact us to request a copy.